Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

José M Entenza

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|August 13, 2005
Beta-lactams against methicillin-resistant Staphylococcus aureusBertrand Guignard, José M Entenza, Philippe Moreillon
Journal of Clinical Microbiology|October 27, 2006
Serological cross-reactivity between different Chlamydia-like organismsNicola Casson, José M Entenza, Gilbert Greub
FEMS Immunology and Medical Microbiology|October 27, 2006
Adherence of Abiotrophia defectiva and Granulicatella species to fibronectin: is there a link with endovascular infections?Laurence Senn, José M Entenza, Guy Prod'hom
The Journal of Antimicrobial Chemotherapy|November 24, 2007
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogensJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureusJacques Vouillamoz, José M Entenza, Peter Hohl, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococciJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
International Journal of Antimicrobial Agents|February 27, 2010
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillinJosé M Entenza, Marlyse Giddey, Jacques Vouillamoz, et al.
FEMS Immunology and Medical Microbiology|November 8, 2006
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditisAlain Bizzini, Siham Beggah-Möller, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2007
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalisPhilippe Moreillon, Walter R Wilson, Roland Leclercq, et al.
Current Infectious Disease Reports|July 11, 2006
New concepts in the pathophysiology of infective endocarditisEleonora Widmer, Yok-Ai Que, José M Entenza, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|August 13, 2005
Beta-lactams against methicillin-resistant Staphylococcus aureusBertrand Guignard, José M Entenza, Philippe Moreillon
Journal of Clinical Microbiology|October 27, 2006
Serological cross-reactivity between different Chlamydia-like organismsNicola Casson, José M Entenza, Gilbert Greub
FEMS Immunology and Medical Microbiology|October 27, 2006
Adherence of Abiotrophia defectiva and Granulicatella species to fibronectin: is there a link with endovascular infections?Laurence Senn, José M Entenza, Guy Prod'hom
The Journal of Antimicrobial Chemotherapy|November 24, 2007
In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogensJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
Antimicrobial Agents and Chemotherapy|October 27, 2004
LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureusJacques Vouillamoz, José M Entenza, Peter Hohl, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2006
Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococciJacques Vouillamoz, Philippe Moreillon, Marlyse Giddey, et al.
International Journal of Antimicrobial Agents|February 27, 2010
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillinJosé M Entenza, Marlyse Giddey, Jacques Vouillamoz, et al.
FEMS Immunology and Medical Microbiology|November 8, 2006
Lack of in vitro biofilm formation does not attenuate the virulence of Streptococcus gordonii in experimental endocarditisAlain Bizzini, Siham Beggah-Möller, Philippe Moreillon, et al.
Antimicrobial Agents and Chemotherapy|March 14, 2007
Single-dose oral amoxicillin or linezolid for prophylaxis of experimental endocarditis due to vancomycin-susceptible and vancomycin-resistant Enterococcus faecalisPhilippe Moreillon, Walter R Wilson, Roland Leclercq, et al.
Current Infectious Disease Reports|July 11, 2006
New concepts in the pathophysiology of infective endocarditisEleonora Widmer, Yok-Ai Que, José M Entenza, et al.
Pageof 4